Does Rallies track congressional trades in EW?

Yes. Rallies tracks politician and congressional stock disclosures for EW, including reported purchases, sales, dates, owners, and trade amounts when available.

Is EW research on Rallies investment advice?

No. Rallies provides research, data, and educational context for EW. It does not provide personalized investment advice.

EW (Edwards Lifesciences) Stock Analysis - Politician Trades

Edwards Lifesciences (EW) is a publicly traded Healthcare sector company. As of May 21, 2026, EW trades at $82.46 with a market cap of $47.44B and a P/E ratio of 43.66. EW moved +0.84% today. Year to date, EW is -1.43%; over the trailing twelve months it is +6.60%. Its 52-week range spans $64.01 to $87.89. Analyst consensus is strong buy with an average price target of $97.80. Rallies surfaces EW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded EW stock?

Recent politician trading activity in EW includes disclosures from Josh Gottheimer, Bruce Westerman, Jefferson Shreve, Bruce Westerman, and Ro Khanna. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

EW Key Metrics

Key financial metrics for EW
Metric	Value
Price	$82.46
Market Cap	$47.44B
P/E Ratio	43.66
EPS	$1.89
Dividend Yield	0.00%
52-Week High	$87.89
52-Week Low	$64.01
Volume	3.24M
Avg Volume	0
Revenue (TTM)	$6.30B
Net Income	$1.09B
Gross Margin	77.87%

Congressional Trades in EW

Josh Gottheimer sale EW on Nov 19, 2025 (amount: $15.00K) for Joint.
Bruce Westerman sale EW on Apr 21, 2025 (amount: $15.00K).
Jefferson Shreve purchase EW on Apr 7, 2025 (amount: $50.00K).
Bruce Westerman purchase EW on Mar 3, 2025 (amount: $15.00K).
Ro Khanna purchase EW on Oct 14, 2024 (amount: $15.00K).

Latest EW News

Edwards Lifesciences jumps on Q1 beat and higher 2026 sales, EPS outlook — Apr 26, 2026
Edwards Lifesciences jumps as Q1 beat drives higher 2026 sales outlook — Apr 25, 2026
Edwards Lifesciences Q1 Sales Up 16.7%, Lifts 2026 Guidance to 9–11% Growth — Apr 24, 2026
Edwards Lifesciences jumps after Q1 beat and higher 2026 sales outlook — Apr 24, 2026
Edwards Lifesciences Lifts 2026 Guidance to 9%–11% After 11% TAVR Growth — Apr 24, 2026

Recent EW Insider Trades

Lippis Daniel J. sold 620 (~$50.31K) on May 18, 2026.
BOBO DONALD E JR sold 9.97K (~$818.11K) on May 15, 2026.
BOBO DONALD E JR sold 8.00K (~$654.57K) on May 15, 2026.

EW Analyst Consensus

17 analysts cover EW: 0 strong buy, 14 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $97.80.

Common questions about EW

Which politicians traded EW stock?: Recent politician trading activity in EW includes disclosures from Josh Gottheimer, Bruce Westerman, Jefferson Shreve, Bruce Westerman, and Ro Khanna. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in EW?: Yes. Rallies tracks politician and congressional stock disclosures for EW, including reported purchases, sales, dates, owners, and trade amounts when available.
Is EW research on Rallies investment advice?: No. Rallies provides research, data, and educational context for EW. It does not provide personalized investment advice.